News
Evidence is growing that some HIV-infected infants, if given antiretroviral drugs early in life, are able to suppress their ...
Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.
Scientific breakthroughs take center stage at the International AIDS Society Conference as global HIV funding and political support erode.
With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...
Receiving treatment within the first month of life could protect children for at least three years, a study suggests.
Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...
Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...
We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...
Resistance to ART was associated with poor clinical outcomes and increased economic burden in a national sample of veterans with HIV infection in the United States.
Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...
To find out what may be behind these numbers, Dr. Ann Khalsa, a clinician at the Valleywise Health McDowell Clinic spoke with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results